These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12044337)

  • 1. Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome.
    van Pampus MG; Wolf H; Koopman MM; van den Ende A; Buller HR; Reitsma PH
    Hypertens Pregnancy; 2001; 20(3):291-8. PubMed ID: 12044337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia.
    Livingston JC; Barton JR; Park V; Haddad B; Phillips O; Sibai BM
    Am J Obstet Gynecol; 2001 Jul; 185(1):153-7. PubMed ID: 11483920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal genotype for specific inherited thrombophilias is not associated with severe preeclampsia.
    Stanley-Christian H; Ghidini A; Sacher R; Shemirani M
    J Soc Gynecol Investig; 2005 Apr; 12(3):198-201. PubMed ID: 15784506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome.
    Benedetto C; Marozio L; Salton L; Maulà V; Chieppa G; Massobrio M
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1095-100. PubMed ID: 12519104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic thrombophilias and preeclampsia: a meta-analysis.
    Lin J; August P
    Obstet Gynecol; 2005 Jan; 105(1):182-92. PubMed ID: 15625161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.
    Karateke A; Haliloglu B; Gurbuz A
    J Matern Fetal Neonatal Med; 2005 Nov; 18(5):299-304. PubMed ID: 16390788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.
    Ganzevoort W; Rep A; De Vries JI; Bonsel GJ; Wolf H;
    Hypertens Pregnancy; 2007; 26(4):433-45. PubMed ID: 18066962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction.
    Schlembach D; Beinder E; Zingsem J; Wunsiedler U; Beckmann MW; Fischer T
    Clin Sci (Lond); 2003 Sep; 105(3):279-85. PubMed ID: 12725641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population.
    Dalmáz CA; Santos KG; Botton MR; Tedoldi CL; Roisenberg I
    Blood Cells Mol Dis; 2006; 37(2):107-10. PubMed ID: 16963292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of factor V Leiden, prothrombin and methylene tetrahydrofolate reductase mutations in women with adverse pregnancy outcomes in Lebanon.
    Zahed LF; Rayes RF; Mahfouz RA; Taher AT; Maarouf HH; Nassar AH
    Am J Obstet Gynecol; 2006 Oct; 195(4):1114-8. PubMed ID: 17000243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.